<p>Number of diseased subjects recruited in control sample (A); Ratio of upper and lower bound of 95% confidence intervals of prevalence odds (B), in a case-base study of 200 distinct subjects (solid lines), 2000 distinct subjects (dashed lines) and 20000 distinct subjects (dotted lines).</p
<p>The standardized incidence ratio and 95% confidence interval of all cancers and different types o...
Number of individuals (N) and prevalence or Absolute Risk (AR) of Attention Deficit Hyperactivity Di...
Number of individuals (N) and prevalence or Absolute Risk (AR) of Attention Deficit Hyperactivity Di...
Numbers of subjects that tested positive at baseline to at least one test- at high cut-off, in sever...
<p>Ref: reference group; N: number; het: heterogeneity; OR: Odds ratio; CI: confidence interval <sup...
<p>Black and grey bars give the prevalence of infectious () and recovered () humans, respectively. N...
<p>Prevalence, odds ratios (ORs), and 95% confidence intervals (CIs) for statin use among sampled su...
<p>Coloured lines represent different amounts of variance explained by the risk score . The odds rat...
Number of patients and controls, and odds ratios of patients to controls, for Q4 Masking Index in QE...
<p>Black and grey bars give the prevalence of infectious () and recovered () humans, respectively. N...
<p>Disease and symptom prevalence estimates including 95% confidence intervals and unadjusted odds r...
<p>Bold solid line: pandemic disease (prevalence 10%-20%); Thin solid line: common disease (1%-5%); ...
<p>Number and proportion of subjects with potential risk factors by seropositive status.</p
Observed and expected prevalence (assuming the diseases occur independently, and based on the preval...
Frequency and percentages of chronic diseases among the study population (N = 201).</p
<p>The standardized incidence ratio and 95% confidence interval of all cancers and different types o...
Number of individuals (N) and prevalence or Absolute Risk (AR) of Attention Deficit Hyperactivity Di...
Number of individuals (N) and prevalence or Absolute Risk (AR) of Attention Deficit Hyperactivity Di...
Numbers of subjects that tested positive at baseline to at least one test- at high cut-off, in sever...
<p>Ref: reference group; N: number; het: heterogeneity; OR: Odds ratio; CI: confidence interval <sup...
<p>Black and grey bars give the prevalence of infectious () and recovered () humans, respectively. N...
<p>Prevalence, odds ratios (ORs), and 95% confidence intervals (CIs) for statin use among sampled su...
<p>Coloured lines represent different amounts of variance explained by the risk score . The odds rat...
Number of patients and controls, and odds ratios of patients to controls, for Q4 Masking Index in QE...
<p>Black and grey bars give the prevalence of infectious () and recovered () humans, respectively. N...
<p>Disease and symptom prevalence estimates including 95% confidence intervals and unadjusted odds r...
<p>Bold solid line: pandemic disease (prevalence 10%-20%); Thin solid line: common disease (1%-5%); ...
<p>Number and proportion of subjects with potential risk factors by seropositive status.</p
Observed and expected prevalence (assuming the diseases occur independently, and based on the preval...
Frequency and percentages of chronic diseases among the study population (N = 201).</p
<p>The standardized incidence ratio and 95% confidence interval of all cancers and different types o...
Number of individuals (N) and prevalence or Absolute Risk (AR) of Attention Deficit Hyperactivity Di...
Number of individuals (N) and prevalence or Absolute Risk (AR) of Attention Deficit Hyperactivity Di...